Amyloid deposition in adults with drug‐resistant temporal lobe epilepsy
Elena Fonseca,Sofía Lallana,Gemma Ortega,Amanda Cano,Silvana Sarria‐Estrada,Deborah Pareto,Manuel Quintana,Carles Lorenzo‐Bosquet,Samuel López‐Maza,Ariadna Gifreu,Daniel Campos‐Fernández,Laura Abraira,Estevo Santamarina,Adelina Orellana,Laura Montrreal,Raquel Puerta,Núria Aguilera,Maribel Ramis,Itziar de Rojas,Agustín Ruiz,Lluis Tárraga,Àlex Rovira,Marta Marquié,Mercè Boada,Manuel Toledo
DOI: https://doi.org/10.1111/epi.18142
IF: 6.74
2024-10-17
Epilepsia
Abstract:Significant amyloid‐β (Aβ) deposition is observed in mesial temporal regions and the ipsilateral anterior cingulate in petients with drug‐resistant temporal lobe epilepsy (TLE). These findings suggest biomarkers of neuronal damage are present in TLE, warranting further investigation. Objective Pathological amyloid‐β (Aβ) accumulation and hyperphosphorylated tau proteins have been described in resected temporal lobe specimens of epilepsy patients. We aimed to determine cerebrospinal fluid (CSF) Aβ1‐42 and p181‐tau levels and cerebral Aβ deposits on positron emission tomography (Aβ PET) and correlate these findings with cognitive performance in adults with drug‐resistant temporal lobe epilepsy (TLE). Methods In this cross‐sectional study, we enrolled individuals with drug‐resistant TLE who were 25–55 years old. Each participant underwent 18F‐flutemetamol PET, determination of CSF Aβ1‐42, p181‐tau, and total tau, and a comprehensive neuropsychological assessment. We evaluated normalized standard uptake value ratios (SUVRs) for different brain regions on Aβ PET. Results Thirty patients (mean age = 41.9 ± SD 8.1 years, 57% men) were included. The median disease duration was 9.5 (interquartile range = 4–24) years. Twenty‐six patients (87%) had a clinically significant cognitive impairment on neuropsychological evaluation, 18 (69%) of the amnesic type. On Aβ PET, high uptake was observed in both mesial temporal regions (ipsilateral: SUVR z‐score = .90, 95% confidence interval [CI] = .60–1.20; contralateral: SUVR z‐score = .92, 95% CI = .57–1.27; p
clinical neurology